Recently Added News
Popular diabetes/weight-loss drugs show additional benefit
Diabetes patients with related chronic kidney disease have better long-term outcomes on GLP1-RA therapies, UTSW researchers find
Stimulating fat cells with GIP receptor has potential to treat obesity
Increasing incretin hormone receptor signaling in fat cells prompts massive weight loss in a lab model, UTSW study shows
AI tool helps identify heart failure risk in diabetes patients
Machine learning model predicts high-risk diabetic cardiomyopathy, revealing potential for targeted prevention
A powerhouse of obesity research – then and now
As weight-loss drugs capture the public’s imagination, UTSW and its Nutrition Obesity Research Center are uniquely positioned to lead the way in discovery, education, and community outreach
Physicians have several online options to refer patients to UT Southwestern: